Blood Test, Combined With MRI, Reduces Harm and Costs When Diagnosing Cancer
Combining a new blood test with MRI cuts the societal cost of prostate cancer screening and reduces the overdiagnosis of low-risk cancers, supporting organized prostate cancer testing in Sweden.